Intense Pulsed-Light Treatment Improves Objective Optical Quality In Patients With Meibomian Gland Dysfunction
Published 2024 - 42nd Congress of the ESCRS
Reference: PO902 | Type: Free paper | DOI: 10.82333/xja5-e177
Authors: Jeongmin Kim 1 , Nala Shin 2 , Woong-Joo Whang 3 , Jae Young Kim 2 , Hungwon Tchah 1 , Kyungmin Koh* 1
1Kim's Eye Hospital, Konyang University College of Medicine,Seoul,Korea, Republic Of, 2Chungnam National University ,Daejeon,Korea, Republic Of, 3Yeouido St. Mary's Hospital, The Catholic University College of Medicine,Seoul,Korea, Republic Of
Purpose
To evaluate changes in objective optical quality following intense pulsed light (IPL) treatment combined with meibomian gland (MG) expression (MGX) in patients with MG dysfunction (MGD).
Setting
Kim's Eye Hospital, Konyang University College of Medicine, Seoul, Republic of Korea
Methods
This retrospective cross-sectional study included MGD-related dry eye disease (DED) patients who received IPL treatment between March and December 2021 at Kim’s Eye Hospital, Seoul, Republic of Korea. Each patient underwent four sessions of IPL treatment using Lumenis M22 (Lumenis Ltd., Yokneam, Israel) and MGX at three-week intervals.
Results
This study included 90 eyes from 45 patients with MGD. The mean age was 52.3±16.1 years (range, 20–75 years), and 53.3% (24/45) of patients were female. Compared with the baseline, all clinical symptoms and signs significantly improved after IPL treatment combined with MGX. All optical quality parameters obtained with an optical quality analysis system (OQAS: Visiometrics, Castelldefels, Spain) have improved significantly over the baseline (p<0.001).
Conclusions
In patients with MGD, IPL treatment combined with MGX improved the objective optical quality and clinical signs and symptoms of DED.